| DARK classics in chemical neuroscience: cocaine LR Drake, PJH Scott ACS chemical neuroscience 9 (10), 2358-2372, 2018 | 55 | 2018 |
| Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting J Tang, R Kuai, W Yuan, L Drake, JJ Moon, A Schwendeman Nanomedicine: Nanotechnology, Biology and Medicine 13 (6), 1869-1878, 2017 | 51 | 2017 |
| Approaches to PET imaging of glioblastoma LR Drake, AT Hillmer, Z Cai Molecules 25 (3), 568, 2020 | 45 | 2020 |
| Classics in neuroimaging: development of PET tracers for imaging monoamine oxidases V Narayanaswami, LR Drake, AF Brooks, JH Meyer, S Houle, ... ACS chemical neuroscience 10 (4), 1867-1871, 2019 | 42 | 2019 |
| Synthesis and Evaluation of [18F]RAGER: A First Generation Small-Molecule PET Radioligand Targeting the Receptor for Advanced Glycation Endproducts BP Cary, AF Brooks, MV Fawaz, LR Drake, TJ Desmond, P Sherman, ... ACS chemical neuroscience 7 (3), 391-398, 2016 | 41 | 2016 |
| Identification of AV-1451 as a weak, nonselective inhibitor of monoamine oxidase LR Drake, JM Pham, TJ Desmond, AV Mossine, SJ Lee, MR Kilbourn, ... ACS Chemical Neuroscience 10 (8), 3839-3846, 2019 | 37 | 2019 |
| Influence of route of administration and lipidation of apolipoprotein AI peptide on pharmacokinetics and cholesterol mobilization J Tang, D Li, L Drake, W Yuan, S Deschaine, EE Morin, R Ackermann, ... Journal of lipid research 58 (1), 124-136, 2017 | 29 | 2017 |
| Characterization of apolipoprotein AI peptide phospholipid interaction and its effect on HDL nanodisc assembly H Patel, B Ding, K Ernst, L Shen, W Yuan, J Tang, LR Drake, J Kang, Y Li, ... International journal of nanomedicine, 3069-3086, 2019 | 27 | 2019 |
| Deuterium Kinetic Isotope Effect Studies of a Potential in Vivo Metabolic Trapping Agent for Monoamine Oxidase B LR Drake, AF Brooks, AJ Mufarreh, JM Pham, RA Koeppe, X Shao, ... ACS chemical neuroscience 9 (12), 3024-3027, 2018 | 16 | 2018 |
| Fluorine-18 patents (2009–2015). Part 1: novel radiotracers AF Brooks, LR Drake, MN Stewart, BP Cary, IM Jackson, D Mallette, ... Pharmaceutical patent analyst 5 (1), 17-47, 2016 | 15 | 2016 |
| Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE) LR Drake, AF Brooks, J Stauff, PS Sherman, J Arteaga, RA Koeppe, ... Journal of Pharmaceutical Analysis 10 (5), 452-465, 2020 | 11 | 2020 |
| First-in-human study of [18F] SynVesT-2, a novel SV2A radioligand with fast kinetics and high specific binding signals Z Cai, L Drake, M Naganawa, S Najafzadeh, R Pracitto, M Lindemann, ... Journal of Nuclear Medicine 61 (supplement 1), 462-462, 2020 | 9 | 2020 |
| Targeted nanoparticles for multimodal imaging of the receptor for advanced glycation end-products LR Drake, PJH Scott Theranostics 8 (22), 6352, 2018 | 8 | 2018 |
| Imaging the receptor for advanced glycation endproducts with [18F] RAGER L Drake, A Brooks, P Scott Journal of Nuclear Medicine 58 (supplement 1), 551-551, 2017 | 4 | 2017 |
| MAO-B Inhibitor Deprenyl Displaces [18F] AV1451 binding on human brain tissue sections and alters uptake in Nonhuman Primate Brain L Drake, J Pham, A Brooks, R Koeppe, P Scott Journal of Nuclear Medicine 60 (supplement 1), 487-487, 2019 | 3 | 2019 |
| Evaluation of enzyme substrate radiotracers as PET/MRS hybrid imaging agents AF Brooks, LR Drake, X Shao, A Zhao, PJH Scott, MR Kilbourn ACS Medicinal Chemistry Letters 9 (11), 1140-1143, 2018 | 3 | 2018 |
| Investigation into RAGE as a biomarker of the LPS-induced murine model of neuroinflammation L Drake, P Scott Journal of Nuclear Medicine 60 (supplement 1), 480-480, 2019 | 2 | 2019 |
| A small molecule radioligand for the intracellular face of RAGE L Drake, P Scott Journal of Nuclear Medicine 59 (supplement 1), 1018-1018, 2018 | 2 | 2018 |
| Imaging the brain’s immune response to alcohol with [11C]PBR28 TSPO Positron Emission Tomography NR Raval, G Angarita, D Matuskey, R Miller, LR Drake, M Kapinos, ... Molecular psychiatry 28 (8), 3384-3390, 2023 | 1 | 2023 |
| [18F] AV1451 is a Weak Inhibitor of Monoamine Oxidase (MAO) A and B L Drake, A Brooks, J Pham, A Mossine, P Scott Journal of Nuclear Medicine 59 (supplement 1), 549-549, 2018 | 1 | 2018 |
